The Philippine Health Insurance Corporation (PhilHealth) announced the new rate of its benefit package for COVID-19 testing. The adjustment resulted from its continuing consultation with stakeholders and infectious disease experts, increased availability and affordability of testing kits in the market, and increased number of qualified facilities to do SARS-CoV-2 testing.
As approved by the PhilHealth Board of Directors, the new rates are as follows:
|Condition for payment||Amount|
|All services for testing are procured and provided by the testing laboratory||P3409|
|Test kits are donated to the testing laboratory||P2077|
|Test kits are donated to the testing laboratory; cost of running the laboratory and RT-PCR machine for testing is included in the facility budget.||P901|
PhilHealth clarified that the package is for costs attributable to services related to testing such as clinical assessment, specimen collection, specimen transport and materials such as PPEs and test kits.
A Circular on pertinent guidelines and date of effectivity will be issued soon.